Product

Increlex^® (mecasermin [rDNA origin] injection)

Increlex^® (mecasermin [rDNA origin] injection) is approved in the United States for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone.

For full prescribing information, visit www.increlex.com.

Authorized Distributors

CuraScript SD Specialty Distribution (Lake Mary, FL)
RxCrossroads (Louisville, KY)